A Review on the Role of Berberine in Addition to Methimazole Compare to Methimazole Alone in the Treatment of Graves’ Disease | Chapter 8 | Novel Research Aspects in Medicine and Medical Science Vol. 7

 This unit aim to highlight the function of Berberine in Addition to Methimazole Compare to   Methimazole Alone in the Treatment of Graves’ Disease (GD).  GD is the most coarse form of hyperthyroidism. The disease has a difficult pathophysiology, and autoimmunity is important.  Thyroid-stimulating Hormone (TSH) inundation from the hyperactive thyroid gland is began by antibodies that stimulate the thyrotropin receptor (TRAb).  It has a negative impact on the cardiovascular arrangement, eyesight, cartilages, and other systems during the whole of the body. The affliction is treated accompanying anti-thyroid drugs, radioactive iodine, or thyroid resection, each of which has benefits and disadvantages.  In this chapter, we will examine the newly found function of the gut-thyroid axis in the pathophysiology of GD. The role of the probiotic Berberine increased the anti-thyroid cure Methimazole in modifying the gut microbiota by growing beneficial bacteria and threatening detrimental microorganisms in the gut is described.  Anti-angering cytokines may be raised and inflammatory cytokines may be curbed as a result, that can regulate the immune scheme more quickly and efficiently than with situation with methimazole alone. Through allure impact on the gut-thyroid shaft, this therapy regimen grant permission finally cause the TRAb to disappear more quickly, and GD to go into pause and be cured.

Author(s) Details:

A. Manov,
Sunrise Health Consortium GME, Las Vegas, Nevada, USA.

S. Chauhan,
Sunrise Health Consortium GME, Las Vegas, Nevada, USA.

S. Donepudi,
Sunrise Health Consortium GME, Las Vegas, Nevada, USA.

Please see the link here: https://stm.bookpi.org/NRAMMS-V7/article/view/12160

Evaluation of Hepatoprotective Activity of Berberis Aristata Root Extract against Chemical-induced Acute Hepatotoxicity in Rats| Chapter 13 | Current Overview on Pharmaceutical Science Vol. 2

 Biotransformation of free radical products, increased lipid peroxidation, and overdone cell end of life are all important determinants causing liver damage persuaded by CCL4. The pharmacological properties of "berberine chloride," a root extract from Berberis aristata, contain antimicrobial, antiviral, anti-instigative, cholesterol-lowering, anticancer, and antioxidant belongings. The present study aimed to explore the deterrent and curative belongings of Berberine on liver tissue harm, liver enzymes, total bilirubin and liver weight. The study was transported at the Department of Pharmacology in collaboration accompanying the Department of Pathology and Biochemistry, MM Institute of Medical Sciences &Research, Mullana, India.  Adult wistar rats aged 7 -9 weeks were introduced with 50% CCl4 intraperitoneally as excellent:1 mixture in liquid paraffin. Berberine was executed intraperitoneally before or after CCl4 situation in various groups. Twenty-four hours subsequently CCl4 injection, levels of liver enzymes (antitoxin alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP)), bilirubin and liver pressure were measured. Histological changes in the liver were too examined accompanying microscopy. The serum levels of liver enzymes and bilirubin were significantly raised (p<0.01) in CCl4-treated group 2 rats.In comparison, group 3-5 rats doctored with CCl4 attended by berberine chloride at doses of 5, 10 and 20 mg/kg, respectively, granted a significant decrease (p<0.05) in levels. The belongings of Berberine were dose-helpless in both pre-and post-situation groups. Histological examination too showed curtailed liver damage in berberine-treated groups. The current study explains that Berberine has both deterrent and curative hepatoprotective belongings against CCl4-induced hepatotoxicity. Berberine has the potential to design new situations against drug-induced hepatotoxicity.

Author(s) Details:

Navdeep Dehar,
Queens University, Kingston, Canada.

Rani Walia,
Department of Pharmacology, MM Institute of Medical Sciences and Research, Mullana, Ambala, Haryana, India.

R. B. Verma,
Department of Pharmacology, MM Institute of Medical Sciences and Research, Mullana, Ambala, Haryana, India.

Pinky Pandey,
Department of Pathology, MM Institute of Medical Sciences and Research, Mullana, Ambala, Haryana, India.

Please see the link here: https://stm.bookpi.org/COPS-V2/article/view/9175

Determination of Antimetastatic and Antitumor Activities of Orally Administered NAX014 Compound in a Murine Model of HER2-Positive Breast Cancer| Chapter 8 | Perspective of Recent Advances in Medical Research Vol. 2

 In this study, we wanted to determine in what way or manner intragastric (IG) administration of the NAX014 compound at a dose of 20 mg/kg would influence the safety, antitumor, and antimetastatic actions as measured for one kinetics of the development of impulsive lung metastases and mammary tumours in HER-2/neu transgenic rodent. It has been demonstrated that the normal isoquinoline alkaloid Berberine (BBR) has a number of healing properties, containing anticancer activity. It has been planned and synthesised to create miscellaneous BBR derivatives so that create new substances accompanying improved anticancer productiveness. We previously accompanied that intraperitoneal (IP) administration of the BBR-derived NAX014 compound was smart to counteract HER-2 overexpressing mammary tumors beginning and progression in transgenic mice. However, the IP presidency was found to encourage organ toxicity at doses above 2.5 mg/Kg. In this study, we evaluated the effect of intragastric (IG) administration of 20 mg/kg of NAX014 on two together safety and anticancer productiveness in HER-2/neu transgenic mice. Furthermore, malignancy cell dissemination and exodus, tumor container senescence and immunological changes were checked. The present study showed that IG NAX014 administration (i) delays the incident of spontaneous mammary tumors in HER-2/neu transgenic rodent without negative effects on strength and survival; (ii) restricts breast malignancy cell migration and often major in vitro and in vivo; (iii) induces artificial and in vivo tumor containers senescence; and (iv) decreases TNF-α and VEGF plasma levels. Despite the fact that NAX014 had no effect on swelling-infiltrating lymphocytes, it was found that mice doctored with NAX014 had lower levels of circulating TNF- and VEGF. The NAX014 compound is argued in the context of the overall judgments as a potential tool for therapeutic approaches against conscience cancers that overexpress HER-2.

Author(s) Details:

Elisa Pierpaoli,
Advanced Technology Center for Aging Research, Scientific Technological Area, IRCCS INRCA, 60121 Ancona, Italy.

Francesco Piacenza,
Advanced Technology Center for Aging Research, Scientific Technological Area, IRCCS INRCA, 60121 Ancona, Italy.

Gaetano Fiorillo,
Naxospharma Srl, 20026 Novate Milanese, Italy.

Paolo Lombardi,
Naxospharma Srl, 20026 Novate Milanese, Italy.

Fiorenza Orlando,
Experimental Animal Models for Aging Unit, Scientific Technological Area, IRCCS INRCA, 60121 Ancona, Italy.

Carmela Salvatore,
Aesis Therapeutics Srl, Incubatore JCube, 60035 Jesi, Italy.

Cristina Geroni,
Aesis Therapeutics Srl, Incubatore JCube, 60035 Jesi, Italy.

Mauro Provinciali,
Advanced Technology Center for Aging Research, Scientific Technological Area, IRCCS INRCA, 60121 Ancona, Italy and Experimental Animal Models for Aging Unit, Scientific Technological Area, IRCCS INRCA, 60121 Ancona, Italy.

Please see the link here: https://stm.bookpi.org/PRAMR-V2/article/view/9016

Influence of Berberine on Megakaryocyte and Apoptotic Cell Populations in Erosive Arthritis | Chapter 9 | Technological Innovation in Pharmaceutical Research Vol. 1

 Berberine (BB) is a protoberberine alkaloid that has a broad range of pharmacological activities and is a Janus kinase (Jak)2/3 inhibitor. However, the mechanisms of berberine's anti-inflammatory effects on joints are still unclear. The aim of this study was to see how berberine affected apoptosis and the generation of senescent cells. The tests were carried out in a mouse model of erosive arthritis caused by intra-articular (i.a.) zymosan injection (zymosan-induced arthritis, ZIA). Sudan Black B (SBB) staining was used to determine histopathologic changes. TRAP and -galactosidase staining is used to determine the differentiation of bone marrow (BM) cells. Flowcytometry was used to assess apoptosis and the expression of Bcl-2 and Bax. Berberine reduced the production of apoptotic and senescent cells in the BM and bone, as well as the development of TRAIL-induced osteoclasts. In synovial cells, the alkaloid had no effect on the expression of anti-apoptotic BcL-2 but did increase the expression of pro-apoptotic Bax. Berberine decreased the amount of megakaryocytes in the BM. Berberine blocked the accelerated production of apoptotic and senescent cells in arthritic mice, potentially reducing joint inflammation.

Author (s) Details

Lyudmila Belenska-Todorova
Medical Faculty, Sofia University, Bulgaria.

Prof. Nina Ivanovska
Institute of Microbiology, Department of Immunology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.

View Book :- https://stm.bookpi.org/TIPR-V1/issue/view/38